Descrizione

Mitophagy pathways including PINK1/Parkin and receptor-mediated mechanisms are depicted, highlighting targets for nutraceutical intervention in AMD-related mitochondrial damage.

Figure 2

Diagram

Source Paper

Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration.

Nutrients (2022)

PMID: 35565950

DOI: 10.3390/nu14091985

Cite This Figure

![Figure 2: Mitophagy pathways including PINK1/Parkin and receptor-mediated mechanisms are depicted, highlighting targets for nutraceutical intervention in AMD-related mitochondrial damage.]()

> Source: Lidianys María Lewis Luján et al. "Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat." *Nutrients*, 2022. PMID: [35565950](https://pubmed.ncbi.nlm.nih.gov/35565950/)

<figure>
  <img src="" alt="Mitophagy pathways including PINK1/Parkin and receptor-mediated mechanisms are depicted, highlighting targets for nutraceutical intervention in AMD-related mitochondrial damage." />
  <figcaption>Figure 2. Mitophagy pathways including PINK1/Parkin and receptor-mediated mechanisms are depicted, highlighting targets for nutraceutical intervention in AMD-related mitochondrial damage.<br>  Source: Lidianys María Lewis Luján et al. "Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35565950/">35565950</a></figcaption>
</figure>

Evidenze correlate

Astaxanthin per Oxidative Stress

Grado C · 3 studi